Global Celecoxib Market Insights and Forecast to 2028

Global Celecoxib Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Celecoxib Product Introduction
1.2 Market by Type
1.2.1 Global Celecoxib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Celecoxib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Celecoxib Sales Estimates and Forecasts 2017-2028
2.2 Global Celecoxib Revenue Estimates and Forecasts 2017-2028
2.3 Global Celecoxib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Celecoxib Sales by Region
2.4.1 Global Celecoxib Sales by Region (2017-2022)
2.4.2 Global Sales Celecoxib by Region (2023-2028)
2.5 Global Celecoxib Revenue by Region
2.5.1 Global Celecoxib Revenue by Region (2017-2022)
2.5.2 Global Celecoxib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Celecoxib Sales by Manufacturers
3.1.1 Global Top Celecoxib Manufacturers by Sales (2017-2022)
3.1.2 Global Celecoxib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Celecoxib in 2021
3.2 Global Celecoxib Revenue by Manufacturers
3.2.1 Global Celecoxib Revenue by Manufacturers (2017-2022)
3.2.2 Global Celecoxib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Celecoxib Revenue in 2021
3.3 Global Celecoxib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Celecoxib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Celecoxib Sales by Type
4.1.1 Global Celecoxib Historical Sales by Type (2017-2022)
4.1.2 Global Celecoxib Forecasted Sales by Type (2023-2028)
4.1.3 Global Celecoxib Sales Market Share by Type (2017-2028)
4.2 Global Celecoxib Revenue by Type
4.2.1 Global Celecoxib Historical Revenue by Type (2017-2022)
4.2.2 Global Celecoxib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Celecoxib Revenue Market Share by Type (2017-2028)
4.3 Global Celecoxib Price by Type
4.3.1 Global Celecoxib Price by Type (2017-2022)
4.3.2 Global Celecoxib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Celecoxib Sales by Application
5.1.1 Global Celecoxib Historical Sales by Application (2017-2022)
5.1.2 Global Celecoxib Forecasted Sales by Application (2023-2028)
5.1.3 Global Celecoxib Sales Market Share by Application (2017-2028)
5.2 Global Celecoxib Revenue by Application
5.2.1 Global Celecoxib Historical Revenue by Application (2017-2022)
5.2.2 Global Celecoxib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Celecoxib Revenue Market Share by Application (2017-2028)
5.3 Global Celecoxib Price by Application
5.3.1 Global Celecoxib Price by Application (2017-2022)
5.3.2 Global Celecoxib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Celecoxib Market Size by Type
6.1.1 North America Celecoxib Sales by Type (2017-2028)
6.1.2 North America Celecoxib Revenue by Type (2017-2028)
6.2 North America Celecoxib Market Size by Application
6.2.1 North America Celecoxib Sales by Application (2017-2028)
6.2.2 North America Celecoxib Revenue by Application (2017-2028)
6.3 North America Celecoxib Market Size by Country
6.3.1 North America Celecoxib Sales by Country (2017-2028)
6.3.2 North America Celecoxib Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Celecoxib Market Size by Type
7.1.1 Europe Celecoxib Sales by Type (2017-2028)
7.1.2 Europe Celecoxib Revenue by Type (2017-2028)
7.2 Europe Celecoxib Market Size by Application
7.2.1 Europe Celecoxib Sales by Application (2017-2028)
7.2.2 Europe Celecoxib Revenue by Application (2017-2028)
7.3 Europe Celecoxib Market Size by Country
7.3.1 Europe Celecoxib Sales by Country (2017-2028)
7.3.2 Europe Celecoxib Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Celecoxib Market Size by Type
8.1.1 Asia Pacific Celecoxib Sales by Type (2017-2028)
8.1.2 Asia Pacific Celecoxib Revenue by Type (2017-2028)
8.2 Asia Pacific Celecoxib Market Size by Application
8.2.1 Asia Pacific Celecoxib Sales by Application (2017-2028)
8.2.2 Asia Pacific Celecoxib Revenue by Application (2017-2028)
8.3 Asia Pacific Celecoxib Market Size by Region
8.3.1 Asia Pacific Celecoxib Sales by Region (2017-2028)
8.3.2 Asia Pacific Celecoxib Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Celecoxib Market Size by Type
9.1.1 Latin America Celecoxib Sales by Type (2017-2028)
9.1.2 Latin America Celecoxib Revenue by Type (2017-2028)
9.2 Latin America Celecoxib Market Size by Application
9.2.1 Latin America Celecoxib Sales by Application (2017-2028)
9.2.2 Latin America Celecoxib Revenue by Application (2017-2028)
9.3 Latin America Celecoxib Market Size by Country
9.3.1 Latin America Celecoxib Sales by Country (2017-2028)
9.3.2 Latin America Celecoxib Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Celecoxib Market Size by Type
10.1.1 Middle East and Africa Celecoxib Sales by Type (2017-2028)
10.1.2 Middle East and Africa Celecoxib Revenue by Type (2017-2028)
10.2 Middle East and Africa Celecoxib Market Size by Application
10.2.1 Middle East and Africa Celecoxib Sales by Application (2017-2028)
10.2.2 Middle East and Africa Celecoxib Revenue by Application (2017-2028)
10.3 Middle East and Africa Celecoxib Market Size by Country
10.3.1 Middle East and Africa Celecoxib Sales by Country (2017-2028)
10.3.2 Middle East and Africa Celecoxib Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Overview
11.1.3 Pfizer Inc Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Inc Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Apotex
11.4.1 Apotex Corporation Information
11.4.2 Apotex Overview
11.4.3 Apotex Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Apotex Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Lupin
11.5.1 Lupin Corporation Information
11.5.2 Lupin Overview
11.5.3 Lupin Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lupin Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lupin Recent Developments
11.6 Hengrui Medicine
11.6.1 Hengrui Medicine Corporation Information
11.6.2 Hengrui Medicine Overview
11.6.3 Hengrui Medicine Celecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hengrui Medicine Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hengrui Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Celecoxib Industry Chain Analysis
12.2 Celecoxib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Celecoxib Production Mode & Process
12.4 Celecoxib Sales and Marketing
12.4.1 Celecoxib Sales Channels
12.4.2 Celecoxib Distributors
12.5 Celecoxib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Celecoxib Industry Trends
13.2 Celecoxib Market Drivers
13.3 Celecoxib Market Challenges
13.4 Celecoxib Market Restraints
14 Key Findings in The Global Celecoxib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Celecoxib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 50mg
Table 3. Major Manufacturers of 100mg
Table 4. Major Manufacturers of 200mg
Table 5. Major Manufacturers of 400mg
Table 6. Global Celecoxib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Celecoxib Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Celecoxib Sales by Region (2017-2022) & (K Units)
Table 9. Global Celecoxib Sales Market Share by Region (2017-2022)
Table 10. Global Celecoxib Sales by Region (2023-2028) & (K Units)
Table 11. Global Celecoxib Sales Market Share by Region (2023-2028)
Table 12. Global Celecoxib Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Celecoxib Revenue Market Share by Region (2017-2022)
Table 14. Global Celecoxib Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Celecoxib Revenue Market Share by Region (2023-2028)
Table 16. Global Celecoxib Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Celecoxib Sales Share by Manufacturers (2017-2022)
Table 18. Global Celecoxib Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Celecoxib Revenue Share by Manufacturers (2017-2022)
Table 20. Celecoxib Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2021)
Table 23. Celecoxib Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Celecoxib Product Offered
Table 25. Date of Manufacturers Enter into Celecoxib Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Celecoxib Sales by Type (2017-2022) & (K Units)
Table 28. Global Celecoxib Sales by Type (2023-2028) & (K Units)
Table 29. Global Celecoxib Sales Share by Type (2017-2022)
Table 30. Global Celecoxib Sales Share by Type (2023-2028)
Table 31. Global Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Celecoxib Revenue Share by Type (2017-2022)
Table 34. Global Celecoxib Revenue Share by Type (2023-2028)
Table 35. Celecoxib Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Celecoxib Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Celecoxib Sales by Application (2017-2022) & (K Units)
Table 38. Global Celecoxib Sales by Application (2023-2028) & (K Units)
Table 39. Global Celecoxib Sales Share by Application (2017-2022)
Table 40. Global Celecoxib Sales Share by Application (2023-2028)
Table 41. Global Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Celecoxib Revenue Share by Application (2017-2022)
Table 44. Global Celecoxib Revenue Share by Application (2023-2028)
Table 45. Celecoxib Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Celecoxib Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Celecoxib Sales by Type (2017-2022) & (K Units)
Table 48. North America Celecoxib Sales by Type (2023-2028) & (K Units)
Table 49. North America Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Celecoxib Sales by Application (2017-2022) & (K Units)
Table 52. North America Celecoxib Sales by Application (2023-2028) & (K Units)
Table 53. North America Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Celecoxib Sales by Country (2017-2022) & (K Units)
Table 56. North America Celecoxib Sales by Country (2023-2028) & (K Units)
Table 57. North America Celecoxib Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Celecoxib Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Celecoxib Sales by Type (2017-2022) & (K Units)
Table 60. Europe Celecoxib Sales by Type (2023-2028) & (K Units)
Table 61. Europe Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Celecoxib Sales by Application (2017-2022) & (K Units)
Table 64. Europe Celecoxib Sales by Application (2023-2028) & (K Units)
Table 65. Europe Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Celecoxib Sales by Country (2017-2022) & (K Units)
Table 68. Europe Celecoxib Sales by Country (2023-2028) & (K Units)
Table 69. Europe Celecoxib Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Celecoxib Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Celecoxib Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Celecoxib Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Celecoxib Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Celecoxib Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Celecoxib Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Celecoxib Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Celecoxib Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Celecoxib Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Celecoxib Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Celecoxib Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Celecoxib Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Celecoxib Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Celecoxib Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Celecoxib Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Celecoxib Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Celecoxib Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Celecoxib Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Celecoxib Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Celecoxib Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Celecoxib Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Celecoxib Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Celecoxib Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Celecoxib Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Celecoxib Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Celecoxib Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Celecoxib Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Celecoxib Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Celecoxib Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer Inc Corporation Information
Table 108. Pfizer Inc Description and Major Businesses
Table 109. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Pfizer Inc Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Inc Recent Developments
Table 112. Teva Corporation Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Teva Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Mylan Corporation Information
Table 118. Mylan Description and Major Businesses
Table 119. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Mylan Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mylan Recent Developments
Table 122. Apotex Corporation Information
Table 123. Apotex Description and Major Businesses
Table 124. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Apotex Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Apotex Recent Developments
Table 127. Lupin Corporation Information
Table 128. Lupin Description and Major Businesses
Table 129. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Lupin Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Lupin Recent Developments
Table 132. Hengrui Medicine Corporation Information
Table 133. Hengrui Medicine Description and Major Businesses
Table 134. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Hengrui Medicine Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hengrui Medicine Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Celecoxib Distributors List
Table 140. Celecoxib Customers List
Table 141. Celecoxib Market Trends
Table 142. Celecoxib Market Drivers
Table 143. Celecoxib Market Challenges
Table 144. Celecoxib Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 3. Global Celecoxib Market Share by Type in 2021 & 2028
Figure 3. 50mg Product Picture
Figure 4. 100mg Product Picture
Figure 5. 200mg Product Picture
Figure 6. 400mg Product Picture
Figure 7. Global Celecoxib Market Share by Application in 2021 & 2028
Figure 8. Rheumatoid arthritis
Figure 9. osteoarthritis
Figure 10. Acute pain
Figure 11. Musculoskeletal pain
Figure 12. Other diseases
Figure 13. Celecoxib Report Years Considered
Figure 14. Global Celecoxib Sales 2017-2028 (K Units)
Figure 15. Global Celecoxib Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Celecoxib Revenue 2017-2028 (US$ Million)
Figure 17. Global Celecoxib Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Celecoxib Sales Market Share by Region (2017-2022)
Figure 19. Global Celecoxib Sales Market Share by Region (2023-2028)
Figure 20. North America Celecoxib Sales YoY (2017-2028) & (K Units)
Figure 21. North America Celecoxib Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Celecoxib Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Celecoxib Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Celecoxib Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Celecoxib Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Celecoxib Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Celecoxib Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Celecoxib Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Celecoxib Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Celecoxib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Celecoxib in the World: Market Share by Celecoxib Revenue in 2021
Figure 32. Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Celecoxib Sales Market Share by Type (2017-2028)
Figure 34. Global Celecoxib Revenue Market Share by Type (2017-2028)
Figure 35. Global Celecoxib Sales Market Share by Application (2017-2028)
Figure 36. Global Celecoxib Revenue Market Share by Application (2017-2028)
Figure 37. North America Celecoxib Sales Market Share by Type (2017-2028)
Figure 38. North America Celecoxib Revenue Market Share by Type (2017-2028)
Figure 39. North America Celecoxib Sales Market Share by Application (2017-2028)
Figure 40. North America Celecoxib Revenue Market Share by Application (2017-2028)
Figure 41. North America Celecoxib Sales Share by Country (2017-2028)
Figure 42. North America Celecoxib Revenue Share by Country (2017-2028)
Figure 43. U.S. Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Celecoxib Sales Market Share by Type (2017-2028)
Figure 46. Europe Celecoxib Revenue Market Share by Type (2017-2028)
Figure 47. Europe Celecoxib Sales Market Share by Application (2017-2028)
Figure 48. Europe Celecoxib Revenue Market Share by Application (2017-2028)
Figure 49. Europe Celecoxib Sales Share by Country (2017-2028)
Figure 50. Europe Celecoxib Revenue Share by Country (2017-2028)
Figure 51. Germany Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 52. France Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Celecoxib Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Celecoxib Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Celecoxib Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Celecoxib Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Celecoxib Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Celecoxib Revenue Share by Region (2017-2028)
Figure 62. China Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 65. India Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Celecoxib Sales Market Share by Type (2017-2028)
Figure 73. Latin America Celecoxib Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Celecoxib Sales Market Share by Application (2017-2028)
Figure 75. Latin America Celecoxib Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Celecoxib Sales Share by Country (2017-2028)
Figure 77. Latin America Celecoxib Revenue Share by Country (2017-2028)
Figure 78. Mexico Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Celecoxib Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Celecoxib Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Celecoxib Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Celecoxib Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Celecoxib Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Celecoxib Revenue Share by Country (2017-2028)
Figure 87. Turkey Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Celecoxib Revenue (2017-2028) & (US$ Million)
Figure 90. Celecoxib Value Chain
Figure 91. Celecoxib Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Methylprednisolone Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......

Global Ibuprofen Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......

Global Mesalazine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......

Global Drugs For Sinusitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......

Global Celecoxib Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Ibuprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Ketoprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......

Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs